Literature DB >> 28732560

[Tubulocystic renal cell carcinoma with poorly differentiated foci].

Fanny Derquin1, S Moreau2, F Dargent3, N Rioux Leclercq4.   

Abstract

Tubulocystic renal cell carcinoma is a rare tumor with an indolent behavior in the majority of cases. In contrast, tubulocystic renal cell carcinoma with poorly differentiated foci has a bad prognosis with an aggressive and metastatic behavior. We present the case of a patient diagnosed with tubulocystic renal cell carcinoma with poorly differentiated foci.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Carcinome tubulokystique; Hereditary leiomyomatosis renal cell carcinoma syndrome; Léiomyomatose héréditaire; Tubulocystic renal cell carcinoma

Mesh：

Year:  2017        PMID： 28732560     DOI： 10.1016/j.annpat.2017.05.003

Source DB:  PubMed          Journal:  Ann Pathol        ISSN： 0242-6498            Impact factor:   0.407


  2 in total

1.  Tubulocystic renal cell carcinoma: Two-case report and literature review.

Authors:  Siwei Xing; Ao Liu; Xiaoqun Yang; Lu Chen; Danfeng Xu
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

2.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.